News & Media

IBA News & Media Room

Spacer

Filter by media type:

Filter by media category:

Filter by date created:

Spacer

Press release

10.10.2015

RadioPharma Solutions

IBA and ICNAS Announce Ga-68 production on Cyclone® 18 using IBA liquid target & Synthera®

EN

>

Press release

22.09.2015

RadioPharma Solutions

IBA RadioPharma Solutions Users Meeting: Joining Forces to Improve the Quality of Cancer Diagnosis

EN

>

Press release

06.06.2015

RadioPharma Solutions

IBA Signs Contract to Install a Cyclone® 18 cyclotron at the University of Chicago

EN

>

Press release

02.07.2014

RadioPharma Solutions

IBA Signs Contract to Install a 70 MeV Cyclotron Dedicated to the Production of Radiopharmaceuticals in Russia

EN

FR

>

Press release

06.06.2014

RadioPharma Solutions

IBA and ABX Announce the Successful Implementation of 18F-FDOPA Nucleophilic Pathway on Synthera® Platform

EN

>

Press release

18.04.2014

RadioPharma Solutions

IBA Selected to Install Three Cyclotrons Cyclone® 18 in China

EN

FR

>

Press release

04.11.2013

RadioPharma Solutions

IBA to Install the First Commercial 70 MeV Cyclotron Dedicated to the Production of Radiopharmaceuticals in the United States

EN

FR

>

Press release

26.10.2012

RadioPharma Solutions

IBA to Launch New Customer CAREprogram during EANM Annual Meeting

EN

>

Press release

07.06.2012

RadioPharma Solutions

The IBA IntegraLab® Team Supports the Penn PET Center for cGMP Compliance

EN

>

Press release

05.06.2012

RadioPharma Solutions

IBA Expands International Customer Base with Two New Major RadioPharmacy Contracts

EN

FR

>

Press release

22.03.2012

RadioPharma Solutions

Market Authorization Obtained in Portugal for the 18F-FDG IBA Synthera® Autoclave Process

EN

>

Press release

26.05.2011

RadioPharma Solutions

The IBA IntegraLab Team Supports PET Centers to be Compliant with the New FDA Regulations

EN

>

Cookies policy

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et des offres adaptés à vos centres d’intérêts.